Moreover, a statistically significant diminution in TNF-α levels was specifically observed in psoriasis and CFS patients, underscoring the therapeutic potential of targeting gut microbiota in managing inflammatory conditions (36). This evidence concerns the gene TNF and myalgic encephalomeyelitis/chronic fatigue syndrome.